Skip to main content
Clinical Trials/PACTR202206535473146
PACTR202206535473146
Other
未知

Comparison of optic nerve perfusion after pan retinal photocoagulation (PRP) versus anti vascular endothelial growth factor (antiVEGF) injection for treatment of high risk proliferative diabetic retinopathy (PDR)

Ain shams university hospital0 sites50 target enrollmentMay 26, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Eye Diseases
Sponsor
Ain shams university hospital
Enrollment
50
Status
Other
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ain shams university hospital

Eligibility Criteria

Inclusion Criteria

  • ? Naive high risk PDR (neovascularization on disc (NVD) more than 1/3 disc area or any NVD with vitreous hemorrhage)
  • ? clear media

Exclusion Criteria

  • ? patients with media opacity
  • ? other retinal and optic nerve diseases rather than diabetic retinopathy
  • ? anti VEGF or steroid intravitreal injection
  • ? previous PRP
  • ? tractional retinal detachment
  • ? glaucoma or any form of optic neuropathy

Outcomes

Primary Outcomes

Not specified

Similar Trials